Gasgon Medical Company Research Report

Company Overview

• Name: Gasgon Medical

• Mission: Driven to tackle challenges in IV infusions to improve patient outcomes and clinician experience by reducing waste, delivering accurate doses, and minimizing risks.

• Founded: No information is available.

• Founders: No information is available.

• Key People:

• Vincent Forde, CEO

• Pauric Carey, Chief Technology Officer

• Dan Stapleton, CFO

• Ciara Weldon, Design Engineer

• Seb Clerkin, Director of RAQA

• James Roche, Lead Design Engineer

• Headquarters: Cork, Ireland

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Developing innovative fluid management products for clinical markets, specifically the AirVault® device which aims to remove air bubbles from IV fluids.

Products

• Products Offered:

• AirVault®

• Product Descriptions:

• AirVault®: A patent-pending, single-use medical device intended to capture air bubbles during IV administration.

• Key Features of AirVault®:

• Closed-system air trap

• Designed to safely and proactively remove air in line

• Helps avoid alarms, maintenance, and care delays during IV infusion

Recent Developments

• Recent Developments:

• Preparation for product launch with the AirVault® device.

• Participated in various conferences and showcased AirVault® at global medical meetings.

• New team members including Pauric Carey (CTO), Ciara Weldon (Design Engineer), Seb Clerkin (Director of RAQA), James Roche (Lead Design Engineer) joined the team.

• New Products Launched: No information is available regarding new product launches apart from the anticipated launch of AirVault®.

• New Features Added to Existing Products: No information is available.

• New Partnerships:

• Collaborative projects with Fundació Sant Joan de Déu for developing IV infusion devices.

• Joint collaboration project with Tada Medical for enhancing the safety of IV infusion systems.

• Awards & Recognitions:

• AirVault® won the NHIA's Innovation Award at the National Home Infusion Awards for its novel approach in IV administration safety.

• Recognized with multiple awards, including the European Health Catapult finals and Seedcorn 2021 as overall winners.

Strategic Initiatives and Future Goals

• Continued engagement in clinical trials and regulatory approval processes for launching its devices.

• Focus on reducing cost and increasing safety for healthcare providers through innovative IV management solutions.

• Ongoing international market expansion efforts, particularly into the US with the help of various acceleration programs and partnerships.

• Collaborative discussions and planning for product improvements and regulatory submissions with partners in Europe.

This structured and detailed company profile highlights Gasgon Medical's position as a promising innovator in the medical device industry, with their focus on improving intravenous therapy solutions through extensive collaboration, product development, and strategic market positioning.